Systemic treatment of colorectal cancer
- 31 December 1993
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (4) , 583-586
- https://doi.org/10.1016/s0959-8049(05)80156-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Sequential methotrexate and 5-fluorouracil (FU) vs. FU alone in metastatic colorectal cancerAnnals of Oncology, 1992
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.Journal of Clinical Oncology, 1992
- Biochemical modulation of 5-fluorouracilCancer Treatment Reviews, 1990
- Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.Journal of Clinical Oncology, 1989
- Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011JNCI Journal of the National Cancer Institute, 1988
- Prognostic factors in advanced colorectal carcinomaThe American Journal of Medicine, 1983
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977